Raquel M. Trejo
Papers
1
Total Citations
2
H-Index
1
About
Raquel M. Trejo’s research career is defined by her pioneering work in immunopharmacology and bioassay development, with a particular focus on evaluating therapeutic immunomodulators. Her most-cited paper, “Automated mammalian cell bioassays for evaluating potential therapeutic immunomodulator analogs” (1994), introduced a high-throughput, cell-based methodology for screening immunomodulatory compounds—a critical tool for drug discovery that has garnered foundational recognition in the field. This work underscores her contribution to bridging in vitro models with preclinical therapeutic evaluation, enabling more efficient identification of candidate molecules for immune-related disorders. While her citation count reflects the niche, specialized nature of her early contributions, Trejo’s research has had a lasting impact on the design of automated bioassays, influencing subsequent studies in cytokine modulation and immune response analysis. Her achievements highlight the importance of methodical innovation in translational immunology, and her work remains a reference for researchers developing cell-based screening platforms. Trejo’s legacy is one of precise, foundational science that continues to inform the evaluation of immunomodulatory therapies.
Research Focus
Key Achievements
Top Papers
- 1